Ikris Pharma
About Us Named Patient Program
Contact Us
Dantrium

Sourced directly from the authorized manufacturer network to ensure authenticity and quality.

You can also access detailed information by clicking Login in the website header.

Dantrium

Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.

Medicine Name: Dantrium
Generic Name (API): Dantrolene Sodium
Dosage Form & Strength: 20 mg
Route: Intravenous (IV) injection
Drug Class: Skeletal muscle relaxant (ryanodine receptor antagonist)

Manufacturer / Innovator:

USA

Regulatory Approval:

  • US FDA (the same active ingredient is marketed in Europe/UK as Agilus)
Family enjoying life with Named Patient Program access

Your Trustedworthy Partner For Named Patient Program

  • your trusted partner for named patient program

    Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.

  • 100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

    100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

  • Medicines sourced from authorized manufacturers with full batch traceability

    Medicines sourced from authorized manufacturers with full batch traceability.

  • EU-GDP Compliant Warehousing for secure, quality-controlled global distribution.

    EU-GDP compliant warehousing for secure, quality-controlled global distribution.

  • Temperature-Controlled Logistics for Safe and Timely Delivery

    Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.

GDP Compliant
Licensed Wholesale distributor

What Is Dantrium Used For?

Dantrium (dantrolene sodium) is a direct-acting skeletal muscle relaxant that blocks calcium release from the sarcoplasmic reticulum. It is indicated for:

  • Treatment of malignant hyperthermia crisis, a rare and life-threatening reaction to certain anesthetic agents
  • Prophylaxis in patients at risk of malignant hyperthermia before anesthesia
  • Prevention of recurrence following an initial malignant hyperthermia reaction

Dantrium is a prescription medicine and must be administered by a physician experienced in managing malignant hyperthermia, in an emergency or perioperative care setting.

Recommended Dosage

  • Malignant hyperthermia crisis: continuous rapid IV push starting at a minimum of 1 mg/kg, continued until symptoms subside, up to a maximum cumulative dose of 10 mg/kg
  • Prophylaxis: 2.5 mg/kg IV, infused over approximately 1 hour, starting about 1.25 hours before anticipated anesthesia
  • Postoperative recurrence prevention: individualized dosing starting with 1 mg/kg or more as clinically indicated

This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.

Dantrium Warnings and Precautions

  • Hepatotoxicity: Dantrolene has been associated with liver injury; liver function should be monitored, particularly with repeated or prolonged use.
  • Muscle weakness: Dantrium can cause significant muscle weakness, which may affect respiratory function; patients should be monitored closely.
  • Extravasation risk: The injection is highly alkaline and can cause tissue damage if it leaks outside the vein; IV access should be secure.
  • Not for chronic spasticity by this route: The intravenous form is intended for acute malignant hyperthermia management, not long-term spasticity treatment.

How to Access Dantrium in India: A 6-Step Process

Step 1 – Search & request your medicine: The treating hospital submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Dantrium to India?

Dantrium (dantrolene sodium) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. Given its use in life-threatening emergencies, hospitals are encouraged to maintain a standing stock through NPP. The following documentation is required:

  • A valid prescription or purchase order from a qualified anesthesiologist or hospital pharmacy
  • Institutional documentation for emergency stock, where applicable
  • Patient or hospital ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription or institutional order and, if applicable, an import permit.

Is Dantrium available in India?

Dantrium (dantrolene sodium injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Dantrium is not commercially marketed in India.

However, hospitals and patients in India can legally access Dantrium through the Named Patient Program (NPP) — an import provision that allows access to medicines approved abroad but not yet marketed in India, under proper regulatory documentation.

Dantrium is FDA-approved in the US for the treatment and prevention of malignant hyperthermia, ensuring full transparency throughout the process.

Dantrium can be made available to hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

The same active ingredient is also marketed as Agilus in Europe and the UK; NPP can source either brand depending on availability and hospital preference.

Sourcing & Delivery of Dantrium

Dantrium is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

  • Storage maintained at 15°C to 30°C throughout transit
  • Real-time shipment tracking and delivery updates
  • Delivery coordinated directly with the treating hospital, including expedited handling for emergency stock requests

Availability of Dantrium Across Major Cities in India

Named Patient Program supports hospital access to Dantrium for malignant hyperthermia emergency preparedness across major cities in India, coordinating documentation, sourcing, and rapid delivery.

Mumbai

Hospitals in Mumbai can stock Dantrium through NPP for anesthesia and critical care emergency readiness.

Delhi

In Delhi, NPP coordinates with hospitals to facilitate timely access to Dantrium for surgical and anesthesia departments.

Bangalore

Bangalore's surgical centers work with NPP to maintain Dantrium stock for malignant hyperthermia preparedness.

Chennai

Hospitals in Chennai can access Dantrium through NPP, with coordination between hospital pharmacy and the program's regulatory and logistics team.

Hyderabad

Hyderabad's surgical and anesthesia centers support access coordination for Dantrium through NPP.

Kolkata

NPP facilitates access to Dantrium for hospitals in Kolkata for perioperative emergency stock.

Pune

Hospitals in Pune can access Dantrium through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Dantrium for hospitals in Ahmedabad.

Kochi

Hospitals in Kochi and across Kerala can access Dantrium through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Dantrium for hospitals in Chandigarh and the surrounding region.

Jaipur

Hospitals in Jaipur can access Dantrium through NPP for surgical emergency preparedness.

Lucknow

NPP facilitates access to Dantrium for hospitals in Lucknow and across Uttar Pradesh.

Bhubaneswar

Hospitals in Bhubaneswar can access Dantrium through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Dantrium for hospitals in Guwahati and across the Northeast region.

NPP also supports hospitals in other Indian cities not listed above — contact the team to check availability and timelines for your location.

Written By:

Written By: Nitin Goswami, Senior Medical Content Writer
Last Updated: 09 September 2026
Sources: FDA • CDSCO

Medically Reviewed By:

Medically Reviewed By: Shilpi Banerjee, Registered Pharmacist (M.Pharm)
Last Updated: 09 September 2026

TRUSTED BY HEALTHCARE PROFESSIONALS & HOSPITALS

Need Help
Accessing Medicines?

Our specialists are here to guide you through every step of the medicine access process.

Let's us help!

Send us a message

Read how to access medicines

Read More arrow icon

Frequently Asked
Questions

Read More